Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S.Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections ReportedThe US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu VaccineThe U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life SciencesModerna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Must-Reads
1
Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown
LIFESTYLE
2
Trump’s Soda Button and 12-Can Habit: A Recipe for Trouble?
LIFESTYLE
3
New FDA-Approved Pill Targets Constant Hunger in Children with PWS
LIFESTYLE
4
Too Much Exercise Might Not Help You Live Longer, Says New Study
LIFESTYLE
5
Novo Nordisk Just Bought the Next Big Thing in Weight Loss
Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S. Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections Reported The US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu Vaccine The U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life Sciences Moderna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Hot Topics